Cutler Group LP Ocuphire Pharma, Inc. Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	BUY	$2.75 - $4.39 $275 - $438	100 Added 100.0%	200 $0
Q4 2021 Jan 18, 2022	SELL	$3.4 - $5.19 $26,520 - $40,482	-7,800 Reduced 98.73%	100 $0
Q2 2021 Jul 19, 2021	BUY	$4.24 - $6.57 $33,496 - $51,903	7,900 New	7,900 $41,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.